Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2009

01-04-2009 | Article

Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens

Comparison of MRSA chromogenic media

Authors: C. Nonhoff, O. Denis, A. Brenner, P. Buidin, N. Legros, C. Thiroux, M. Dramaix, M. J. Struelens

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2009

Login to get access

Abstract

This study compares the performance of three chromogenic culture agar plates, chromID MRSA, MRSA-Screen and MRSA-Select, by challenging with a collection of Staphylococcus aureus strains and screening samples obtained from hospitalised patients. All chromogenic media showed excellent sensitivity (>95%) and specificity after 18 h on the methicillin-resistant Staphylococcus aureus (MRSA) collection strains, but the specificity of MRSA-Screen decreased markedly after 42 h. Sixty-eight of 1,002 screening specimens yielded MRSA on at least one medium. The sensitivity of all media to detecting MRSA after 18 h was <50%, but this increased to 75% (chromID MRSA), 81% (MRSA-Screen) and 72% (MRSA-Select) after 42 h and 85% after enrichment and plating on the same media. The specificity at 18 h was excellent, but was significantly lower for MRSA-Screen after 42 h and enrichment. In conclusion, all media showed equivalent sensitivities after 18 h of incubation and performed better when enriched before inoculation. MRSA-Screen was more sensitive but less specific than the two other media after 42 h of incubation.
Literature
1.
go back to reference Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10(4):781–791PubMed Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10(4):781–791PubMed
2.
go back to reference Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed
3.
go back to reference Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG et al (2005) Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 56(6):1103–1106 doi:10.1093/jac/dki379 PubMedCrossRef Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG et al (2005) Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 56(6):1103–1106 doi:10.​1093/​jac/​dki379 PubMedCrossRef
4.
go back to reference Karchmer TB, Durbin LJ, Simonton BM, Farr BM (2002) Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51(2):126–132 doi:10.1053/jhin.2002.1200 PubMedCrossRef Karchmer TB, Durbin LJ, Simonton BM, Farr BM (2002) Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51(2):126–132 doi:10.​1053/​jhin.​2002.​1200 PubMedCrossRef
5.
go back to reference Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H et al (2006) Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63(Suppl 1):S1–S44 doi:10.1016/j.jhin.2006.01.001 PubMedCrossRef Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H et al (2006) Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63(Suppl 1):S1–S44 doi:10.​1016/​j.​jhin.​2006.​01.​001 PubMedCrossRef
6.
go back to reference Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ et al (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56(6):1000–1018 doi:10.1093/jac/dki372 PubMedCrossRef Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ et al (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56(6):1000–1018 doi:10.​1093/​jac/​dki372 PubMedCrossRef
7.
go back to reference Gorss EB (1992) Prospective, focused surveillance for oxacillin-resistant Staphylococcus aureus. In: Clinical microbiology procedures handbook. ASM Press, Washington, DC, pp 15.1–15.2 Gorss EB (1992) Prospective, focused surveillance for oxacillin-resistant Staphylococcus aureus. In: Clinical microbiology procedures handbook. ASM Press, Washington, DC, pp 15.1–15.2
8.
go back to reference Le Groupement pour le Dépistage, l’Etude et la Prévention des Infections Hospitalières—Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH–GOSPIZ) (2003). Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Available online at: http://www.belgianinfectioncontrolsociety.be Le Groupement pour le Dépistage, l’Etude et la Prévention des Infections Hospitalières—Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH–GOSPIZ) (2003). Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Available online at: http://​www.​belgianinfection​controlsociety.​be
9.
go back to reference Gaillot O, Wetsch M, Fortineau N, Berche P (2000) Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol 38(4):1587–1591PubMed Gaillot O, Wetsch M, Fortineau N, Berche P (2000) Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol 38(4):1587–1591PubMed
10.
go back to reference Carricajo A, Treny A, Fonsale N, Bes M, Reverdy ME, Gille Y et al (2001) Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J Clin Microbiol 39(7):2581–2583 doi:10.1128/JCM.39.7.2581-2583.2001 PubMedCrossRef Carricajo A, Treny A, Fonsale N, Bes M, Reverdy ME, Gille Y et al (2001) Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J Clin Microbiol 39(7):2581–2583 doi:10.​1128/​JCM.​39.​7.​2581-2583.​2001 PubMedCrossRef
12.
go back to reference Denis O, Deplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R et al (2006) In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50(8):2680–2685 doi:10.1128/AAC.00272-06 PubMedCrossRef Denis O, Deplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R et al (2006) In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50(8):2680–2685 doi:10.​1128/​AAC.​00272-06 PubMedCrossRef
13.
go back to reference Hallin M, Denis O, Deplano A, De Mendonça R, De Ryck R, Rottiers S et al (2007) Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey. J Antimicrob Chemother 59(3):465–472 doi:10.1093/jac/dkl535 PubMedCrossRef Hallin M, Denis O, Deplano A, De Mendonça R, De Ryck R, Rottiers S et al (2007) Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey. J Antimicrob Chemother 59(3):465–472 doi:10.​1093/​jac/​dkl535 PubMedCrossRef
14.
go back to reference Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ (2002) Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 40(4):1514–1517 doi:10.1128/JCM.40.4.1514-1517.2002 PubMedCrossRef Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ (2002) Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 40(4):1514–1517 doi:10.​1128/​JCM.​40.​4.​1514-1517.​2002 PubMedCrossRef
15.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Approved standard MS100-S17. CLSI (formerly NCCLS), Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Approved standard MS100-S17. CLSI (formerly NCCLS), Wayne, PA
16.
go back to reference Roisin S, Nonhoff C, Denis O, Struelens MJ (2008) Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J Clin Microbiol 46(8):2525–2528 doi:10.1128/JCM.00291-08 PubMedCrossRef Roisin S, Nonhoff C, Denis O, Struelens MJ (2008) Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J Clin Microbiol 46(8):2525–2528 doi:10.​1128/​JCM.​00291-08 PubMedCrossRef
18.
go back to reference Compernolle V, Verschraegen G, Claeys G (2007) Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45(1):154–158 doi:10.1128/JCM.01115-06 PubMedCrossRef Compernolle V, Verschraegen G, Claeys G (2007) Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45(1):154–158 doi:10.​1128/​JCM.​01115-06 PubMedCrossRef
19.
go back to reference Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA et al (2005) Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43(11):5536–5540 doi:10.1128/JCM.43.11.5536-5540.2005 PubMedCrossRef Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA et al (2005) Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43(11):5536–5540 doi:10.​1128/​JCM.​43.​11.​5536-5540.​2005 PubMedCrossRef
20.
go back to reference Louie L, Soares D, Meaney H, Vearncombe M, Simor AE (2006) Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(12):4561–4563 doi:10.1128/JCM.01763-06 PubMedCrossRef Louie L, Soares D, Meaney H, Vearncombe M, Simor AE (2006) Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(12):4561–4563 doi:10.​1128/​JCM.​01763-06 PubMedCrossRef
21.
23.
go back to reference Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R et al (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(2):637–639 doi:10.1128/JCM.44.2.637-639.2006 PubMedCrossRef Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R et al (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(2):637–639 doi:10.​1128/​JCM.​44.​2.​637-639.​2006 PubMedCrossRef
24.
go back to reference van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J (2007) Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 45(8):2486–2490 doi:10.1128/JCM.00139-07 PubMedCrossRef van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J (2007) Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 45(8):2486–2490 doi:10.​1128/​JCM.​00139-07 PubMedCrossRef
26.
go back to reference Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F et al (2005) Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 55(3):379–382 doi:10.1093/jac/dki017 PubMedCrossRef Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F et al (2005) Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 55(3):379–382 doi:10.​1093/​jac/​dki017 PubMedCrossRef
27.
28.
go back to reference Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 40(8):2766–2771 doi:10.1128/JCM.40.8.2766-2771.2002 PubMedCrossRef Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 40(8):2766–2771 doi:10.​1128/​JCM.​40.​8.​2766-2771.​2002 PubMedCrossRef
29.
go back to reference de San N, Denis O, Gasasira MF, De Mendonça R, Nonhoff C, Struelens MJ (2007) Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens. J Clin Microbiol 45(4):1098–1101 doi:10.1128/JCM.02208-06 PubMedCrossRef de San N, Denis O, Gasasira MF, De Mendonça R, Nonhoff C, Struelens MJ (2007) Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens. J Clin Microbiol 45(4):1098–1101 doi:10.​1128/​JCM.​02208-06 PubMedCrossRef
30.
go back to reference Amsterdam D (1996) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Lippincott Williams & Wilkins, Baltimore, MD, pp 52–111 Amsterdam D (1996) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Lippincott Williams & Wilkins, Baltimore, MD, pp 52–111
Metadata
Title
Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens
Comparison of MRSA chromogenic media
Authors
C. Nonhoff
O. Denis
A. Brenner
P. Buidin
N. Legros
C. Thiroux
M. Dramaix
M. J. Struelens
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0637-9

Other articles of this Issue 4/2009

European Journal of Clinical Microbiology & Infectious Diseases 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.